Catalyst Wire Dossier Catalyst Wire Dossier

RAP-103

· Clarent Biopharma, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RAP-103, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of RAP-103 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects [Phase 2]

See pricing